Globus Medical, Inc.

Equities

GMED

US3795772082

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:02 2024-07-05 pm EDT 5-day change 1st Jan Change
68.76 USD +0.20% Intraday chart for Globus Medical, Inc. +0.39% +29.03%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
You can't escape politics Our Logo
ANALYST RECOMMENDATIONS : Adobe, Nike, Solaredge, Welltower, Spectris... Our Logo
Globus Medical, Inc.(NYSE:GMED) dropped from Russell Midcap Growth Index CI
Globus Medical, Inc.(NYSE:GMED) dropped from Russell 3000 Growth Index CI
Globus Medical, Inc.(NYSE:GMED) dropped from Russell 3000E Growth Index CI
Globus Medical, Inc.(NYSE:GMED) dropped from Russell 1000 Growth-Defensive Index CI
Globus Medical, Inc.(NYSE:GMED) dropped from Russell 2500 Growth Index CI
Globus Medical, Inc.(NYSE:GMED) dropped from Russell Small Cap Comp Growth Index CI
Globus Medical, Inc.(NYSE:GMED) dropped from Russell 1000 Growth Index CI
Globus Medical, Inc.(NYSE:GMED) dropped from Russell 1000 Value-Defensive Index CI
Globus Medical, Inc.(NYSE:GMED) dropped from Russell 1000 Defensive Index CI
RBC Raises Price Target on Globus Medical to $76 From $70, Maintains Outperform Rating MT
Orthofix Medical Inc. Appoints Aviva Mcpherron as President of Global Operations and Quality CI
BTIG Adjusts Globus Medical's Price Target to $72 From $63, Keeps Buy Rating MT
Piper Sandler Upgrades Globus Medical to Overweight From Neutral, Adjusts Price Target to $80 From $60 MT
Globus Medical Insider Sold Shares Worth $4,090,022, According to a Recent SEC Filing MT
Morgan Stanley Raises Price Target on Globus Medical to $67 From $57, Keeps Equalweight Rating MT
Globus Medical Insider Sold Shares Worth $1,300,000, According to a Recent SEC Filing MT
Barclays Adjusts Price Target on Globus Medical to $85 From $83, Maintains Overweight Rating MT
Sector Update: Health Care Stocks Slipping Wednesday Afternoon MT
Sector Update: Health Care MT
Globus Medical Shares Rise After Stifel, Truist Adjust Price Targets Upwards MT
Stifel Adjusts Price Target on Globus Medical to $70 From $64, Maintains Buy Rating MT
Truist Securities Raises Price Target on Globus Medical to $63 From 60, Maintains Hold Rating MT
Globus Medical Q1 Non-GAAP Earnings, Sales Rise; 2024 Guidance Boosted MT
Chart Globus Medical, Inc.
More charts
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions with a focus on improving the quality of life of patients with musculoskeletal disorders. The Company offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the majority of conditions affecting the spine, including degenerative conditions, deformity, tumors, and trauma. It provides solutions that facilitate both open and minimally invasive surgery (MIS) techniques. It includes traditional fusion implants, such as pedicle screws and rod systems. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
68.76 USD
Average target price
71.67 USD
Spread / Average Target
+4.23%
Consensus
  1. Stock Market
  2. Equities
  3. GMED Stock
  4. News Globus Medical, Inc.
  5. Globus Medical Launches Precice Bone Transport in Select Markets